US OptionsDetailed Quotes
RIGL250117P18000
- 1.76
- 0.000.00%
15min DelayClose Jan 6 16:00 ET
0.00High0.00Low
1.76Open1.76Pre Close0 Volume1 Open Interest18.00Strike Price0.00Turnover76.59%IV2.17%PremiumJan 17, 2025Expiry Date1.40Intrinsic Value100Multiplier11DDays to Expiry0.36Extrinsic Value100Contract SizeAmericanOptions Type-0.7056Delta0.1583Gamma9.43Leverage Ratio-0.0339Theta-0.0035Rho-6.65Eff Leverage0.0099Vega
Rigel Pharmaceuticals Stock Discussion
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
No comment yet